The effect of Biofeedback therapy on Anxiety and Depression in Parkinson's disease: a Pilot Study.

IF 2.5 4区医学 Q2 CLINICAL NEUROLOGY

Journal of Movement Disorders Pub Date : 2025-07-14 DOI:10.14802/jmd.25097

Justus Chun-Yu Chen, Tzu-Yun Tseng, Jong-Ling Fuh, Yu-Hsiang Cheng, Dai-Wei Lin, Han-Lin Chiang

{"title":"The effect of Biofeedback therapy on Anxiety and Depression in Parkinson's disease: a Pilot Study.","authors":"Justus Chun-Yu Chen, Tzu-Yun Tseng, Jong-Ling Fuh, Yu-Hsiang Cheng, Dai-Wei Lin, Han-Lin Chiang","doi":"10.14802/jmd.25097","DOIUrl":null,"url":null,"abstract":"Objective: This pilot study aimed to evaluate the feasibility and potential effects of biofeedback therapy (BT) on anxiety and depression in patients with Parkinson's disease (PD).Methods: A randomized waitlist-controlled trial was conducted involving 19 patients with PD and comorbid anxiety and/or depression. Anxiety and depression were assessed at baseline, post-treatment, and one-month follow-up.Results: All 19 patients completed the study. Compared with the control group, significant improvements were observed immediately after BT in the Hamilton Depression Rating Scale and the anxiety subscale of the Hospital Anxiety and Depression Scale (HADS), but not in the HADS depression subscale. In the pooled analysis, the anxiolytic effect persisted at one-month follow-up, with greater improvements observed in those with more severe baseline anxiety.Conclusion: These preliminary findings suggest that BT may help reduce anxiety symptoms in PD. Future studies with larger, more severely affected cohorts are needed to confirm these findings.","PeriodicalId":16372,"journal":{"name":"Journal of Movement Disorders","volume":" ","pages":""},"PeriodicalIF":2.5000,"publicationDate":"2025-07-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Movement Disorders","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.14802/jmd.25097","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}

引用次数: 0

Abstract

Objective: This pilot study aimed to evaluate the feasibility and potential effects of biofeedback therapy (BT) on anxiety and depression in patients with Parkinson's disease (PD).

Methods: A randomized waitlist-controlled trial was conducted involving 19 patients with PD and comorbid anxiety and/or depression. Anxiety and depression were assessed at baseline, post-treatment, and one-month follow-up.

Results: All 19 patients completed the study. Compared with the control group, significant improvements were observed immediately after BT in the Hamilton Depression Rating Scale and the anxiety subscale of the Hospital Anxiety and Depression Scale (HADS), but not in the HADS depression subscale. In the pooled analysis, the anxiolytic effect persisted at one-month follow-up, with greater improvements observed in those with more severe baseline anxiety.

Conclusion: These preliminary findings suggest that BT may help reduce anxiety symptoms in PD. Future studies with larger, more severely affected cohorts are needed to confirm these findings.

查看原文本刊更多论文

生物反馈疗法对帕金森病焦虑和抑郁的影响：一项初步研究。

目的：本初步研究旨在评价生物反馈疗法（BT）治疗帕金森病（PD）患者焦虑和抑郁的可行性和潜在效果。方法：对19例PD合并焦虑和/或抑郁患者进行随机对照试验。在基线、治疗后和一个月的随访中评估焦虑和抑郁。结果：所有19例患者均完成了研究。与对照组相比，治疗后汉密尔顿抑郁评定量表和医院焦虑抑郁量表（HADS）焦虑子量表均有显著改善，但HADS抑郁子量表无显著改善。在综合分析中，抗焦虑效果在一个月的随访中持续存在，在基线焦虑更严重的患者中观察到更大的改善。结论：这些初步发现提示BT可能有助于减轻PD患者的焦虑症状。未来需要对更大、更严重的受影响人群进行研究，以证实这些发现。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊